Mounjaro and Erectile Dysfunction: What We Know Right Now

Does the medicine itself cause the problem, or is something else going on?

The decision most men facing this question are actually trying to make is a simple one: is Mounjaro safe to take if I already have erectile dysfunction, and could it make things worse? The short answer, based on current evidence, is that tirzepatide is not expected to cause or worsen erectile dysfunction. It does not appear in the medicine's SmPC as a recognised adverse effect, and the large-scale SURMOUNT clinical trials involving thousands of adults did not identify it as a concern.

What can cause short-term changes to energy, libido and general wellbeing is the calorie deficit that often accompanies the early weeks on any effective weight-loss treatment. When appetite drops sharply and calorie intake falls, the body temporarily prioritises essential functions. Some men notice lower energy or reduced sexual interest during this adjustment phase. This is not a direct pharmacological effect of tirzepatide on sexual function, it is the body adapting to eating less. The titration period tends to be the phase where this is most noticeable, and it typically settles.

Separately, the medicines used to treat conditions that commonly coexist with obesity (certain antihypertensives, for instance) can themselves affect erectile function. If you have recently started other treatments alongside Mounjaro, that is worth raising with your GP.

How weight loss may actually help erectile function over time

Obesity and erectile dysfunction share a cluster of underlying mechanisms, which is why addressing one can meaningfully affect the other. Excess body fat (particularly visceral fat) is associated with higher circulating oestrogen, lower free testosterone, impaired vascular endothelial function and low-grade systemic inflammation. Each of these contributes to erectile dysfunction through distinct pathways. For men with obesity, erectile dysfunction is not always a standalone condition; often it reflects the same metabolic strain driving their weight.

Sustained weight loss addresses several of these pathways at once. Testosterone levels frequently rise as body fat falls. Blood pressure and vascular function tend to improve. Insulin sensitivity (another factor in erectile function) improves alongside it. You can read about how tirzepatide works at a physiological level to understand why the metabolic changes it drives are broad, not just about the number on the scale.

The evidence for weight-loss-driven improvements in erectile function comes from multiple studies of significant weight reduction, including bariatric surgery research, and is plausible given these mechanisms. Tirzepatide-specific evidence on this outcome is still emerging, but there is no reason to expect it to behave differently from other interventions producing similar degrees of weight loss. The SURMOUNT-1 trial, published in the New England Journal of Medicine, documented average body-weight reductions of around 20–21% at the highest dose, the kind of change that can shift metabolic markers substantially.

When erectile dysfunction before starting Mounjaro needs its own conversation

Erectile dysfunction is sometimes an early warning of cardiovascular disease. Because the penile arteries are small, they are often the first vessels to show the effects of atherosclerosis, insulin resistance or hypertension, conditions that also raise the background risk of heart attack and stroke. A man who has noticed progressive erectile dysfunction alongside significant excess weight may have an underlying picture that deserves clinical attention before, or alongside, starting weight-loss treatment.

This is not a reason to avoid Mounjaro. It is a reason to have an honest conversation with a prescriber. At nume, every consultation is personally read by a GPhC-registered Independent Prescriber who can assess whether any concurrent conditions need flagging to your GP. The consultation is free, and there is no obligation. If you are curious about the broader treatment landscape, our weight-loss overview is a useful starting point.

For men already managing erectile dysfunction with prescribed treatments, it is worth noting that any medicine affecting gastric emptying (including tirzepatide) may influence the absorption timing of oral medicines taken around the same time. This is rarely clinically significant for PDE5 inhibitors, which have wide therapeutic margins, but it is worth mentioning to your prescriber so they have the full picture. Questions sometimes also arise about the form in which the medicine is taken, and our page on pastile Mounjaro covers what patients should know about that presentation. The NHS medicines page for tirzepatide provides a patient-level overview of known interactions and effects.

What to do if erectile dysfunction develops or worsens on treatment

If you are already taking Mounjaro and notice changes in erectile function, the first practical step is to consider timing. Did it coincide with a dose increase? With a significant drop in calorie intake? With starting another medicine? Pinning down the timeline helps your prescriber assess what is driving it.

Do not stop tirzepatide without speaking to your prescriber first. A planned dose pause or a slower titration is sometimes enough to allow the body to adjust, and stopping abruptly can reverse the metabolic progress you have made. Your prescriber can also check whether any reversible cause is in play, including circumstances such as recent surgery, since our page on Mounjaro after a c-section illustrates how recovery context can shape prescribing decisions. The functional properties of tirzepatide explain why its effects on the body are interconnected, changes during treatment are rarely isolated to one system.

For context on how the cost of treatment fits into your overall picture, the Eli Lilly price increase page sets out what has happened to Mounjaro pricing in the UK since September 2025. The MHRA's Yellow Card scheme is the right place to report any suspected side effect, including any you believe may be linked to Mounjaro, reports from real patients are how the post-market safety picture is built.

If, after reading all of this, you'd like a prescriber to look at your specific situation, you can speak to our prescribers through a free consultation. There is no pressure, and no clinical commitment on either side until the full picture has been assessed.